Prostaglandin I2 contributes to the vasodepressor effect of baicalein in hypertensive rats

Hypertension

Volumn 31, Issue 3, 1998, Pages 866-871

  Takizawa, Hideki ^a   DelliPizzi, Annmarie ^a   Nasjletti, Alberto ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

12 1ipoxygenase; Angiotensin II; Lipoxygenase inhibitors; Prostacyclin synthase; Prostaglandin I2

Indexed keywords

ANGIOTENSIN; ARACHIDONATE 12 LIPOXYGENASE; BAICALEIN; ICOSANOID; LIPOXYGENASE INHIBITOR; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; ANGIOTENSIN II; ENZYME INHIBITOR; FLAVANONE DERIVATIVE; FLAVONOID; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; RAT; URINARY EXCRETION; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BLOOD PRESSURE; ENZYME INHIBITORS; EPOPROSTENOL; FLAVANONES; FLAVONOIDS; HYPERTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS;

EID: 0031594456     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.866     Document Type: Article

References (30)

1. Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1993;90:4947-4951.
2. Baba A, Kimoto M, Tatsuno T, Inoue T, Iwata H. Membrane-bound lipoxgenase of rat cerebral micro vessels. Biochem Biophys Res Commun. 1985;127:283-288.
3. Rosolowsky M, Falck JR, Willerson JT, Campbell WB. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res. 1990;66:608-621.
4. Yamamoto S. Mammalian lipoxygenase: molecular structures and functions. Biochem Biophys Acta. 1992;1128:117-131.
5. Salmon JA, Smith DR, Flower RJ, Moncada A, Vane JR. Further studies on the enzymatic conversion of prostaglandin endoperoxides into prostacyclin by porcine aorta microsomes. Biochem Biophys Acta. 1978;523:250-262.
6. 2-mediated mechanism of vascular contraction in hypertensive rats: relation to lipoxygenase and prostacyclin synthase activities. Circ Res. 1994;74:197-205.
7. Ma YH, Harder DR, Clark JE, Roman RJ. Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol. 1991;261:H451-H456.
8. Natarajan R, Gonzales N, Lanting L, Nadler J. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle hypertrophy. Hypertension. 1994;23(suppl I):I-142-I-147.
9. Saito F, Hori MT, Ideguchi Y, Berger M, Golub M, Stern N, Tuck ML. 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension. 1992;20:138-143.
10. Kisch ES, Jaffe A, Knoll E, Stern N. Role of the lipoxygenase pathway in angiotensin II-induced vasoconstriction in the human placenta. Hypertension. 1997;29:796-801.
11. Nozawa K, Tuck ML, Golub M, Eggena P, Nadler JL, Stern N. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol. 1990;259:H1774-H1780.
12. Stern N, Golub M, Nozawa K, Berger M, Knoll E, Yanagawa N, Natarajan R, Nadler JL, Tuck ML. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol. 1989: 257:H434-H443.
13. Stem N, Nozawa K, Golub M, Eggena P, Knoll E, Tuck ML. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat. Am J Hypertens. 1993;6:52-58.
14. Stern N, Kisch E, Knoll E. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension. 1996;27:1149-1152.
15. Powell WS, Funk CD. Metabolism of arachidonic acid and other polyunsaturated fatty acids by blood vessels. Prog Lipid Res. 1987;26:183-210.
16. Mistry M, Nasjletti A. Prostanoids as mediators of prohypertensive and antihypertensive mechanisms. Am J Med Sci. 1988;31:263-267.
17. Diz D, Baer PG, Nasjletti A. Angiotensin II-induced hypertension in the rat: effects on the plasma concentration, renal excretion and tissue release of prostaglandins. J Clin Invest. 1983;72:466-477.
18. Sekiya K, Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun. 1982;105:1090-1095.
19. 1α, 15-hydroxy-9α-11α (epoxymethano)prosta-5,13-dienoic acid and 15-hydroxy-11α,9α(epoxymethano) prosta-5,13-dienoic acid. Prostagland Med. 1979;2:177-189.
20. 2 in the rat circulation. Biochem Biophys Acata. 1980;620:186-192.
21. 2 as a circulating vasodepressor hormone in the normotensive and spontaneously hypertensive rat. Prostaglandins. 1980;20:1053-1060.
22. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985;57:1170-1173.
23. Powell WS. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 1982;86:467-477.
24. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
25. Rajagopaian S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vascular tone. J Clin Invest. 1996;97:1916-1923.
26. Ham EA, Egan RW, Soderman DD, Gale PH, Kuehl FA. Peroxidase-dependent deactivation of prostacyclin synthetase. J Biol Chem. 1979;254: 2191-2194.
27. Barchowsky A, Tabrizi K, Kent RS, Whorton AR. Inhibition of prostaglandin synthesis after metabolism of menadione by culture porcine endothelial cells. J Clin Invest. 1989;83:1153-1159.
28. Uehara Y, Shirahase H, Nagata T, Ishimitsu T, Morishita S, Osumi S, Matsuoka H, Sugimoto T. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension. 1990;15:216-224.
29. Mora A, Paya M, Rios JL, Alcaraz MJ. Structure-activity relationship of polymethoxyflavone and other flavonoids as inhibitors of nonenzymatic lipid peroxidation. Biochem Pharmacol. 1990;40:793-797.
30. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M, Scaccini C. Inhibition of human low density lipoprotein oxidation by caffeic acid and other hydroxycinnamic derivatives. Free Radic Biol Med. 1995;19:541-552.